Full clinical trials are taking place and vaccines being rolled out have gone through full regulatory checks. As with all new drugs and vaccines there will be on-going safety checks.
We are not aware of any specific side effects of a COVID-19 vaccine that would be unique to people with endocrine conditions or diabetes mellitus, in the same way as there are no concerns about other vaccines. Each of the vaccines that are being developed have different potential side effects. If you have concerns about a COVID-19 vaccination, check the NHS vaccine pages to see if your queries are answered there. For any individual circumstances, you may need to talk to your GP.
All those in the categories below will get letters to call them in for vaccinating
JCVI advises that the first priorities for the COVID-19 vaccination programme should be the prevention of mortality and the maintenance of the health and social care systems. As the risk of mortality from COVID-19 increases with age, prioritisation is primarily based on age. The order of priority for each group in the population corresponds with data on the number of individuals who would need to be vaccinated to prevent one death, estimated from UK data obtained from March to June 2020:
- residents in a care home for older adults and their carers
- all those 80 years of age and over and frontline health and social care workers
- all those 75 years of age and over
- all those 70 years of age and over and clinically extremely vulnerable individuals[footnote 1]
- all those 65 years of age and over
- all individuals aged 16 years[footnote 2] to 64 years with underlying health conditions which put them at higher risk of serious disease and mortality. This also includes those who are in receipt of a carer’s allowance, or those who are the main carer of an elderly or disabled person whose welfare may be at risk if the carer falls ill.
- all those 60 years of age and over
- all those 55 years of age and over
- all those 50 years of age and over
This page will be updated and shared as and when any new information or guidance arises